CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Knight Therapeutics Inc Company Snapshot
Knight Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Knight Therapeutics Inc with three other companies in this sector in Canada: Polydex Pharmaceuticals Limited (2017 sales of 8.70 million Canadian Dollars [US$6.82 million] ), Acerus Pharmaceuticals Corporation (8.35 million Canadian Dollars [US$6.54 million] ), and Intellipharmaceutics International Incorporation (7.17 million Canadian Dollars [US$5.62 million] ).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Knight Therapeutics Inc
  Stock Performance Chart for Knight Therapeutics Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 7.79
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks 0.5%  
4 Weeks -2.5%   52 Weeks -24.0%  
 
Knight Therapeutics Inc Key Data:
  Ticker: GUD Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 8,634,000
(Year Ending Jan 2018).
Employees: 29
  Currency: Canadian Dollars Market Cap: 1,112,506,236
  Fiscal Yr Ends: December Shares Outstanding: 142,812,097
  Share Type: Common Closely Held Shares: N/A
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.